The health industry is a complex system, and reimbursement is the lifeblood. Reduction in payments from governmental and commercial payors affects providers, suppliers, manufacturers, and all others across the health care continuum.
Regulatory approval and accreditation is the heart of the system. For many, delay in licensure and other regulatory approvals can threaten financing and corporate viability. Accreditation of residency training programs is essential to the vitality of academic medical centers and teaching hospitals.
Restructuring is a fact of life in this dynamic system. Our clients are frequently involved in mergers, acquisitions, joint ventures, and strategic affiliations to achieve and maintain viability and a leadership position in the marketplace.
Mintz Levin’s health law attorneys work on the most complicated and sensitive legal matters, from managing government investigations with potential civil, administrative, and criminal liability, to structuring multi-million dollar corporate transactions. Our cross-disciplinary approach equips Mintz Levin attorneys to solve problems throughout the industry, enabling our clients to focus on what counts: providing cost-effective, quality patient care.
|
|
|
|
Health industry executives and governing boards rely on Mintz Levin to help address the complex operational issues on their leadership agendas. We deliver an A-team of lawyers and government relations professionals with a track record of making the system work. Many of our attorneys have served as in-house counsel or have held government positions. Using diverse perspectives and skills, we help health industry clients to address and solve regulatory, business, financial, transactional, and operational problems and challenges every day.
Mintz Levin’s Health Law Practice has received national recognition for its accomplishments, particularly in the legal and health industry media. Our dedicated team consists of over 30 full-time health law attorneys. One of the most respected health care industry publications, Modern Healthcare, cites Mintz Levin among the top 15 largest health care law firms in the U.S., and the American Health Lawyers Association granted Mintz Levin an Award of Excellence based on the size of its Health Law Practice. Chambers USA: America’s Leading Lawyers for Business 2010 recognized Mintz Levin’s Health Law Practice in Boston, New York, and Washington, D.C., as well as Nationwide for the East Coast, and lists six Mintz Levin Health Law attorneys as leaders in their field. Over the past several years, Nightingale’s Healthcare News has named Mintz Levin Health Law attorneys to its lists of Outstanding Healthcare Fraud and Compliance Lawyers, Outstanding Hospital Lawyers, Outstanding Healthcare Transaction Lawyers, Outstanding Young Healthcare Lawyers, and Outstanding Healthcare Antitrust Lawyers. Five of our Health Law attorneys were selected for the 2011 edition of The Best Lawyers in America. Massachusetts and New York Super Lawyers also identified five Mintz Levin attorneys as leading health law lawyers.
Faced with inadequate reimbursement, aging facilities, and patient demand for new technologies and treatments, many hospitals and other health care providers are hard-pressed to find enough capital to meet their future needs. Funding sources for capital projects are changing, and funds from traditional sources (such as tax-exempt and taxable bonds, equity, debt financing, philanthropy, and equipment leases) have dropped sharply. Despite these trends, capital is available—even to health care entities with challenging or distressed financial profiles.
Mintz Levin lawyers help health industry clients determine what is possible and create strategies to make it happen. For some, we structure joint ventures and strategic alliances with payors, management companies, and providers. For emerging health industry companies, we help find venture capital and other private and institutional financing, arrange corporate research and marketing partnerships, and secure technology and intellectual property licensing that leverage additional sources of available capital. Our clients rely on us to expand their business and the reach of the services they provide.
Since 2006, Mintz Levin has completed over 130 health industry mergers and acquisitions totaling over $45 billion; venture capital deals totaling over $1 billion; 51 strategic collaborations totaling $1.6 million; and 168 other financings totaling nearly $8 billion.
Mintz Levin encourages all attorneys to provide pro bono legal services to the community, and believes that an organized, firm-sponsored program is critical to enabling its lawyers to undertake such efforts. The legal services furnished through Mintz Levin’s pro bono program are wide-ranging, and clients include needy individuals as well as groups who are fighting poverty, homelessness, and domestic violence; seeking civil rights, economic justice, and access to health care; and addressing other acute social needs. As a signatory to the Pro Bono Institute's Pro Bono ChallengeSM, Mintz Levin has committed to dedicating 3% of all billable hours on pro bono matters.
For example, Mintz Levin has provided legal and strategic advice to The Kenneth B. Schwartz Center since its inception. Founded in 1995 by Kenneth B. Schwartz, a highly respected attorney in Mintz Levin’s Health Law Practice, shortly before his death from lung cancer at age 40, The Schwartz Center is dedicated to strengthening the relationship between patients and caregivers in the changing health care system. Mintz Levin’s service to The Schwartz Center has included board participation, the development of its bylaws, advice on trademark issues, assistance with contract matters, other strategic advice, and government relations representation. Over the past year alone, more than 40 Mintz Levin attorneys have devoted over 1500 hours to this pro bono representation.
Please click here for a pdf of our Health Law brochure.
5/23/2011
5/16/2011
5/9/2011
5/6/2011
5/2/2011
4/27/2011
4/15/2011
4/11/2011
4/6/2011
4/6/2011
4/5/2011
4/4/2011
4/1/2011
3/27/2011
3/23/2011
3/20/2011
3/13/2011
3/6/2011
2/28/2011
2/25/2011
2/23/2011
Karen S. Lovitch, Carrie A. Roll, Rachel M. Irving, Katina W. Lee and Ellyn L. Sternfield
BNA's Health Care Fraud Report
2/20/2011
2/14/2011
Stephen M. Weiner and Daria Niewenhous
HealthLeaders Media
2/14/2011
2/13/2011
2/6/2011
2/3/2011
2/2011
Theresa C. Carnegie and Karen S. Lovitch
G-2 Compliance Report
1/28/2011
1/26/2011
1/25/2011
Ellyn L. Sternfield
Law360
1/25/2011
1/21/2011
1/18/2011
1/12/2011
BNA's Health Care Fraud Report
1/12/2011
12/29/2010
12/17/2010
12/17/2010
11/23/2010
11/15/2010
11/4/2010
11/2/2010
10/25/2010
10/13/2010
9/30/2010
9/28/2010
9/27/2010
9/16/2010
9/8/2010
9/1/2010
8/24/2010
8/17/2010
8/9/2010
7/28/2010
7/23/2010
7/21/2010
7/13/2010
7/2/2010
7/2010
Jennifer E. Williams
HCCA Compliance Today
6/30/2010
6/30/2010
6/21/2010
6/18/2010
6/16/2010
5/27/2010
5/26/2010
5/25/2010
5/18/2010
5/17/2010
5/13/2010
5/7/2010
4/29/2010
4/27/2010
4/26/2010
4/23/2010
Thomas S. Crane, Karen S. Lovitch, Stephen M. Weiner, Katina W. Lee and Tara E. Swenson
BNA's Medicare Report
4/22/2010
4/21/2010
Hope S. Foster, Sarah A. Kaput and Jennifer E. Williams
The Food and Drug Law Institute
4/14/2010
4/13/2010
4/7/2010
Thomas S. Crane, Brian P. Dunphy, Hope S. Foster, Sarah A. Kaput, Karen S. Lovitch, Jennifer E. Williams
BNA Health Care Fraud Report
4/2010
Karen S. Lovitch, Stephen R. Bentfield and Dianne J. Bourque
G-2 Compliance Perspectives
3/26/2010
3/24/2010
3/15/2010
3/4/2010
2/3/2010
1/20/2010
1/15/2010
1/11/2010
1/7/2010
1/4/2010
1/4/2010
1/4/2010
12/31/2009
12/28/2009
11/23/2009
11/17/2009
Doug Sherwin
The San Diego Daily Transcript
11/4/2009
10/29/2009
10/23/2009
10/16/2009
8/26/2009
8/19/2009
8/3/2009
7/29/2009
7/17/2009
7/13/2009
7/1/2009
6/26/2009
6/2/2009
5/28/2009
5/21/2009
5/14/2009
5/7/2009
5/4/2009
4/30/2009
4/30/2009
4/23/2009
4/13/2009
4/6/2009
4/1/2009
3/25/2009
3/23/2009
3/18/2009
3/13/2009
2/26/2009
2/10/2009
2/9/2009
1/28/2009
1/27/2009
1/16/2009
1/13/2009
1/12/2009
1/2009
Garrett G. Gillespie and Brian P. Dunphy
HFMA Massachusetts-Rhode Island Chapter, Mass Media (Volume XXXVI Issue 2)
12/23/2008
12/19/2008
12/18/2008
Jennifer Williams and Heather Westphal
BNA Health Law Reporter
12/2008
Daria Niewenhous and Nancy Sterling
Oncology Issues
9/9/2008
7/10/2008
7/2008
Nili S. Yolin and M. Daria Niewenhous
Oncology Issues
5/19/2008
2/8/2008
1/2008
M. Daria Niewenhous and Sarah Whipple
Oncology Issues
1/2008
Thomas S. Crane
Journal of Health & Life Sciences Law
12/17/2007
Margaret D. Kranz, Andrew B. Roth
New York Law Journal
9/26/2007
Mintz Levin's Health Law Practice
Bureau of National Affairs
9/2007
M. Daria Niewenhous, Deborah Daccord, and Melissa O'Neill
Oncology Issues
8/8/2007
6/22/2007
6/22/2007
6/21/2007
6/21/2007
5/15/2007
4/3/2007
4/1/2007
3/21/2007
2/28/2007
2/27/2007
2/21/2007
2/13/2007
2/2/2007
1/25/2007
12/1/2006
11/28/2006
11/1/2006
9/18/2006
9/8/2006
9/1/2006
7/1/2006
6/19/2006
6/2/2006
5/1/2006
4/21/2006
4/7/2006
4/1/2006
3/29/2006
3/1/2006
2/15/2006
2/14/2006
1/1/2006
1/1/2006
7/30/2005
6/1/2005
5/6/2005
5/1/2005
4/30/2005
4/21/2005
3/15/2005
3/14/2005
2/2/2005
1/31/2005
11/25/2004
10/14/2004
9/27/2004
7/1/2004
5/7/2004
4/14/2004
2/2/2004
12/19/2003
12/10/2003
12/3/2003
11/26/2003
9/12/2003
7/25/2003
7/21/2003
6/2/2003
5/28/2003
5/14/2003
4/15/2003
3/28/2003
1/1/2003
11/1/2002
9/1/2002
8/1/2002
4/5/2002
4/1/2002
4/1/2002
4/1/2002
3/1/2002
3/1/2002
3/1/2002
2/1/2002
1/1/2002
11/1/2001
6/17/2001
5/1/2001
3/1/2001
2/1/2001
1/24/2001
1/1/2001
1/1/2001
12/1/2000
11/2/2000
11/1/2000
11/1/2000
9/1/2000
6/1/2000
6/1/2000
5/1/2000
4/1/2000
2/1/2000
1/1/2000